$5 million to assist Pacific island nations develop and implement country-specific HIV/AIDS prevention

NewsGuard 100/100 Score

Australia will provide $5 million for a Pacific HIV/AIDS Grant Scheme to assist Pacific island nations develop and implement country-specific HIV/AIDS prevention and information campaigns.

The scheme is part of Australia's broader regional HIV/AIDS program, designed to reduce the spread of the disease and mitigate the effects on people living with HIV/AIDS.

The establishment of the grant scheme demonstrates Australia's partnership with our Pacific neighbours. We recognise that the Asia-Pacific region could become the new epicentre of the global pandemic if vigorous and effective responses are not strengthened and increased.

The scale of the challenge needs to be clearly understood - with one million new infections last year, there are now 7.4 million people living with HIV/AIDS in the Asia-Pacific.

That is why Australia is intensifying efforts to tackle the looming HIV/AIDS crisis in our region by more than doubling our funding - to $600 million by 2010 - to combat the virus and prevent an African-style tragedy.

Pacific countries must not underestimate the severity of the threat posed by HIV/AIDS. The disease impacts on every level of society. It is one of the greatest threats to the economic and social development, stability, and security of developing countries.

Australia is working with our Pacific neighbours to put in place effective and practical programs to ensure the region does not succumb to this terrible disease.

Strong and visible leadership at all levels and sectors of government and civil society in the Pacific is critical if the impact of HIV/AIDS is to be minimised.

Australia's Special Representative on HIV/AIDS, Ms Annmaree O'Keeffe, is in Fiji today to launch the scheme which is available to Fiji, Vanuatu, Samoa, Kiribati, Tonga, Solomon Islands, Tuvalu, Marshall Islands, Cook Islands, Niue, Tokelau, Federated States of Micronesia, Palau and Nauru.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Interferon-beta deficiency alters brain response in neuroHIV mouse model